Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Sarcoma 1Gynecologic 1

Conditions

Thymoma 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 17Filgrastim 16Ifosfamide 13Etoposide 13Paclitaxel 11Peripheral Blood Stem Cell Transplantation 10Cisplatin 6Thiotepa 5Therapeutics 5Cyclophosphamide 5Temozolomide 4Psychiatric Rehabilitation 4Polymerase Chain Reaction 4Granulocyte Colony-Stimulating Factor 4Flow Cytometry 4Bleomycin 4Taxes 3Radiotherapy 3Methylprednisolone 3Magnetic Resonance Spectroscopy 3Amplified Fragment Length Polymorphism Analysis 3Amifostine 3sargramostim 2pegfilgrastim 2liposomal amphotericin B 2ixabepilone 2etoposide phosphate 2aldesleukin 2aflibercept 2Trastuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × isophosphamide mustard × Gynecologic × Clear all
NCT01242072 2012-07-18

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

Alaunos Therapeutics

Phase 1 Unknown
12 enrolled
GenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Osteosarcoma, Testicular Neoplasms, Thymoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡